OUR PRODUCTS

MOBILE APPS

GENERAL INFO

INBX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INBX is expected to report earnings to fall 15.14% to -157 cents per share on November 13

Inhibrx Biosciences INBX Stock Earnings Reports

Q3'25

Est.

$-1.57

Q2'25

Missed

by $0.30

Q1'25

Missed

by $1.39

Q4'24

Missed

by $1.65

Q3'24

Missed

by $1.36

The last earnings report on August 13 showed earnings per share of -185 cents, missing the estimate of -154 cents. With 112.49K shares outstanding, the current market capitalization sits at 375.39M.

View a ticker or compare two or three

Compare

INBX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For INBX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INBX showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company, which engages in researching and developing biotechnology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11025 N. Torrey Pines Road

Phone

+1 858 795-4220

Employees

172

Web

https://www.inhibrx.com